Raj Kumar

18PUBLICATIONS
20CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 24, 2026
Design and synthesis of N-3-substituted quinazolinone derivatives as anticancer agents targeting EGFR.

|May 25, 2026
Design and Pictet-Spengler enabled synthesis of carboxamide-substituted imidazo[1,2-a]quinoxalines as dual EGFR and tubulin targeting anticancer agents.

|Mar 06, 2026
Synthesis of New Substituted 5H-Benzo[e]imidazo[1,2-a][1,4]diazepines via Pictet-Spengler Reaction and Their Neuroprotective and Anticonvulsant Evaluation.

Manvendra Kumar, Shubham Upadhayay, Pritam Maity

|Jan 14, 2025
Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents.

Gaurav Joshi, Umesh Prasad Yadav, Zahid Rafiq

|Dec 19, 2024
2-(4-Bromobenzyl) tethered 4-amino aryl/alkyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines: design, synthesis, anticancer assessment via dual topoisomerase-I/II inhibition, and in silico studies.

Sahil Arora, Bhagyshree Patra, Isha Dhamija

|Jul 19, 2024
Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor.

Manvendra Kumar, Kiran T Patil, Pritam Maity

Pageof 3

Frequent Collaborators

8 joint publications

Gaurav Joshi

5 joint publications

Manvendra Kumar

3 joint publications

Sahil Arora

2 joint publications

Ashoke Sharon